Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations

Carcinogenesis

Volumn 34, Issue 4, 2013, Pages 787-798

  Toh, Soo Ting ^a   Jin, Yu ^a   Liu, Lizhen ^a   Wang, Jingbo ^a   Babrzadeh, Farbod ^b   Gharizadeh, Baback ^b   Ronaghi, Mostafa ^b,c   Toh, Han Chong ^c   Chow, Pierce Kah Hoe ^d,e   Chung, Alexander Y F ^e   Ooi, London L P J ^c,e   Lee, Caroline G L ^a,c,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

^e SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; HEPATITIS B VIRUS X PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE;

AMINO ACID SUBSTITUTION; ARTICLE; CHROMOSOME 10; CLINICAL ARTICLE; DISEASE ASSOCIATION; EXON; GENETIC VARIABILITY; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; VIRAL GENETICS; VIRUS DNA CELL DNA INTERACTION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

AMINO ACID SUBSTITUTION; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE; CHROMOSOMES, HUMAN, PAIR 10; DNA, VIRAL; GENETIC VARIATION; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LIVER NEOPLASMS; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; TELOMERASE; TRANS-ACTIVATORS; VIRUS INTEGRATION;

EID: 84875932668     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs406     Document Type: Article

References (70)

1. Lupberger,J. et al. (2007) Hepatitis B virus-induced oncogenesis. World J. Gastroenterol., 13, 74-81.
2. Taras,D. et al. (2006) Halofuginone suppresses the lung metastasis of chemically induced hepatocellular carcinoma in rats through MMP inhibition. Neoplasia, 8, 312-318.
3. Grise,F. et al. (2012) Rnd3/RhoE Is down-regulated in hepatocellular carcinoma and controls cellular invasion. Hepatology, 55, 1766-1775.
4. Chang,M.H. (2003) Decreasing incidence of hepatocellular carcinoma among children following universal hepatitis B immunization. Liver Int., 23, 309-314.
5. Kumar,M. et al. (2007) Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. J. Gastroenterol. Hepatol., 22, 1104-1111.
6. Hassan,M.M. et al. (2002) Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology, 36, 1206-1213.
7. Yang,H.I. et al. Taiwan Community-Based Cancer Screening Project Group. (2002) Hepatitis B e antigen and the risk of hepatocellular carcinoma. N. Engl. J. Med., 347, 168-174.
8. Parkin,D.M. et al. (2001) Cancer burden in the year 2000. The global picture. Eur. J. Cancer, 37 (suppl. 8), S4-66.
9. Lian,Z. et al. (2001) A cellular gene up-regulated by hepatitis B virusencoded X antigen promotes hepatocellular growth and survival. Hepatology, 34, 146-157.
10. Bonilla Guerrero,R. et al. (2005) The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma. J. Hepatol., 42, 760-777.
11. Buendia,M.A. (1992) Hepatitis B viruses and hepatocellular carcinoma. Adv. Cancer Res., 59, 167-226.
12. Robinson,W.S. (1994) Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma. Annu. Rev. Med., 45, 297-323.
13. Feitelson,M.A. et al. (2007) Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Lett., 252, 157-170.
14. Shafritz,D.A. et al. (1981) Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. N. Engl. J. Med., 305, 1067-1073.
15. Koch,S. et al. (1984) Amplification and rearrangement in hepatoma cell DNA associated with integrated hepatitis B virus DNA. EMBO J., 3, 2185-2189.
16. Matsubara,K. et al. (1990) Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis. Mol. Biol. Med., 7, 243-260.
17. Steinemann,D. et al. (2006) Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization. Clin. Gastroenterol. Hepatol., 4, 1283-1291.
18. Minami,M. et al. (2005) Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis. Oncogene, 24, 4340-4348.
19. Ferber,M.J. et al. (2003) Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene, 22, 3813-3820.
20. Schlüer,V. et al. (1994) Integrated hepatitis B virus X and 3' truncated preS/S sequences derived from human hepatomas encode functionally active transactivators. Oncogene, 9, 3335-3344.
21. Ng,R.K. et al. (2004) cDNA microarray analysis of early gene expression profiles associated with hepatitis B virus X protein-mediated hepatocarcinogenesis. Biochem. Biophys. Res. Commun., 322, 827-835.
22. Hildt,E. et al. (2002) The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice. EMBO J., 21, 525-535.
23. Bui-Nguyen,T.M. et al. (2010) Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein HBx requires MTA1 coregulator. J. Biol. Chem., 285, 6980-6986.
24. Du,Y. et al. (2012) Elevation of highly up-regulated in liver cancer (Hulc) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating P18. J. Biol. Chem., 287, 26302-26311.
25. Kim,C.M. et al. (1991) HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature, 351, 317-320.
26. Becker,S.A. et al. (1998) Hepatitis B virus X protein interferes with cellular DNA repair. J. Virol., 72, 266-272.
27. Su,F. et al. (1997) Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc. Natl. Acad. Sci. U.S.A., 94, 8744-8749.
28. Brëhot,C. et al. (1981) State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases. Proc. Natl. Acad. Sci. U.S.A., 78, 3906-3910.
29. Dejean,A. et al. (1984) Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11-base-pair direct repeat. Proc. Natl. Acad. Sci. U.S.A., 81, 5350-5354.
30. Chen,J.Y. et al. (1988) Detection of hepatitis B virus DNA in hepatocellular carcinoma: analysis by hybridization with subgenomic DNA fragments. Hepatology, 8, 518-523.
31. Gozuacik,D. et al. (2001) Identification of human cancer-related genes by naturally occurring Hepatitis B Virus DNA tagging. Oncogene, 20, 6233-6240.
32. Wang,Y. et al. (2004) Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated X gene and hepatocellular carcinogenesis. Oncogene, 23, 142-148.
33. Murakami,Y. et al. (2005) Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut, 54, 1162-1168.
34. Tamori,A. et al. (2005) Alteration of gene expression in human hepatocellular carcinoma with integrated hepatitis B virus DNA. Clin. Cancer Res., 11, 5821-5826.
35. Saigo,K. et al. (2008) Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed-lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma. Hum. Mutat., 29, 703-708.
36. Jiang,Z. et al. (2012) The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. Genome Res., 22, 593-601.
37. Sung,W.K. et al. (2012) Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat. Genet., 44, 765-769.
38. Binladen,J. et al. (2007) The use of coded PCR primers enables highthroughput sequencing of multiple homolog amplification products by 454 parallel sequencing. PLoS ONE, 2, e197.
39. Lee,A.T. et al. (2005) The hepatitis B virus X protein sensitizes HepG2 cells to UV light-induced DNA damage. J. Biol. Chem., 280, 33525-33535.
40. Fourel,G. et al. (1994) Evidence for long-range oncogene activation by hepadnavirus insertion. EMBO J., 13, 2526-2534.
41. Jang,J.W. et al. (2012) Mutational complex genotype of the hepatitis B virus X/precore regions as a novel predictive marker for hepatocellular carcinoma. Cancer Sci., 103, 296-304.
42. Xiao,L. et al. (2011) Hepatitis B virus genotype B with G1896A and A1762T/G1764A mutations is associated with hepatitis B related acuteon-chronic liver failure. J. Med. Virol., 83, 1544-1550.
43. Mohamadkhani,A. et al. (2009) Downregulation of HLA class II molecules by G1896A pre-core mutation in chronic hepatitis B virus infection. Viral Immunol., 22, 295-300.
44. Hung,C.H. et al. (2012) Precore/core promoter mutations and hepatitis B virus genotype in hepatitis B and C dually infected patients treated with interferon-based therapy. Antiviral Res., 93, 55-63.
45. Waltz,T.L. et al. (2005) Development of a molecular-beacon assay to detect the G1896A precore mutation in hepatitis B virus-infected individuals. J. Clin. Microbiol., 43, 254-258.
46. Chen,R.Y. et al. (2003) Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine-resistant HBV in vitro. Hepatology, 37, 27-35.
47. Uchida,T. et al. (1997) Mutations of the X region of hepatitis B virus and their clinical implications. Pathol. Int., 47, 183-193.
48. Baptista,M. et al. (1999) High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers. Hepatology, 29, 946-953.
49. Ahn,S.H. et al. (2003) Sequence variation upstream of precore translation initiation codon reduces hepatitis B virus e antigen production. Gastroenterology, 125, 1370-1378.
50. Ren,X. et al. (2010) Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis. J. Viral Hepat., 17, 887-895.
51. Lin,X. et al. (2005) Biological impacts of "hot-spot" mutations of hepatitis B virus X proteins are genotype B and C differentiated. World J. Gastroenterol., 11, 4703-4708.
52. Hussain,Z. et al. (2009) Genetic dissection of naturally occurring basal core promoter mutations of hepatitis B virus reveals a silent phenotype in the overlapping X gene. J. Gen. Virol., 90(Pt 9), 2272-2281.
53. Kim,H.J. et al. (2008) Hepatitis B virus X mutations occurring naturally associated with clinical severity of liver disease among Korean patients with chronic genotype C infection. J. Med. Virol., 80, 1337-1343.
54. Horikawa,I. et al. (2001) cis-Activation of the human telomerase gene (hTERT) by the hepatitis B virus genome. J. Natl. Cancer Inst., 93, 1171-1173.
55. Minami,M. et al. (2006) Unusually high incidence of hepatitis B virus integration into the MLL gene in hepatocellular carcinoma. Clin. Cancer Res., 12(11 Pt 1), 3549; author reply 3549-3549; author reply 3550.
56. Rose,A.B. (2008) Intron-mediated regulation of gene expression. Curr. Top. Microbiol. Immunol., 326, 277-290.
57. De Miglio,M.R. et al. (2001) Frequent loss of heterozygosity at the Hcr1 (hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strain. Hepatology, 33, 1110-1117.
58. Fujiwara,Y. et al. (2000) PTEN/MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas. Jpn. J. Cancer Res., 91, 287-292.
59. Takahashi,K. et al. (1993) Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma. Hepatology, 17, 794-799.
60. Nagaya,T. et al. (1987) The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma. Genes Dev., 1, 773-782.
61. Yip,W.K. et al. (2011) Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma development. PLoS ONE, 6, e22888.
62. Liu,X. et al. (2008) Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses. Carcinogenesis, 29, 1207-1214.
63. Sirma,H. et al. (1999) Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene, 18, 4848-4859.
64. Tu,H. et al. (2001) Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res., 61, 7803-7810.
65. Huo,T.I. et al. (2001) Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis. Oncogene, 20, 3620-3628.
66. Liu,X. et al. (2008) Hepatitis B virus X protein mutants exhibit distinct biological activities in hepatoma Huh7 cells. Biochem. Biophys. Res. Commun., 373, 643-647.
67. Ma,N.F. et al. (2008) COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis. Clin. Cancer Res., 14, 5061-5068.
68. Cheng,A.S. et al. (2007) RNA interference targeting HBx suppresses tumor growth and enhances cisplatin chemosensitivity in human hepatocellular carcinoma. Cancer Lett., 253, 43-52.
69. Bergametti,F. et al. (2002) Turnover of hepatitis B virus X protein is regulated by damaged DNA-binding complex. J. Virol., 76, 6495-6501.
70. Uzun,Y. et al. (2006) Hepatitis B core antigen expression pattern reflects the response to anti-viral treatment. J. Gastroenterol. Hepatol., 21, 977-981.